Peter J. Kushner

发表

Structure and specificity of nuclear receptor-coactivator interactions.

R J Fletterick, J D Baxter, R. Fletterick, 1998, Genes & development.

Mechanisms of thyroid hormone action: insights from X-ray crystallographic and functional studies.

R. Fletterick, J. Baxter, P. Kushner, 1998, Recent progress in hormone research.

Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities.

M. Stallcup, P. Kushner, Han Ma, 1998, Molecular endocrinology.

Estrogen receptor activation function 1 works by binding p160 coactivator proteins.

B. Katzenellenbogen, P. Webb, D. Chen, 1998, Molecular endocrinology.

Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway.

M. Karin, P. Webb, P. Kushner, 2001, Molecular endocrinology.

Oestrogen receptor function at classical and alternative response elements.

D. Agard, P. Webb, G. Greene, 2000, Novartis Foundation symposium.

Mutations in the conserved C-terminal sequence in thyroid hormone receptor dissociate hormone-dependent activation from interference with AP-1 activity

E. Zandi, M. Karin, J. Baxter, 1997, Molecular and cellular biology.

Titration by estrogen receptor activation function-2 of targets that are downstream from coactivators.

J. Baxter, P. Webb, G. Greene, 1999, Molecular endocrinology.

Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein

Y. Sadovsky, J. Baxter, P. Webb, 1995, Molecular and cellular biology.

Construction of cell lines that express high levels of the human estrogen receptor and are killed by estrogens.

J. Shine, J. Baxter, G. Greene, 1990, Molecular endocrinology.

Estrogen receptor accessory proteins: effects on receptor-DNA interactions.

G. Greene, P. Kushner, C. Landel, 1995, Environmental health perspectives.

Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities.

M. Stallcup, Han Ma, H. Hong, 1998, Molecular Endocrinology.

Increased activator protein-1 DNA binding and c-Jun NH2-terminal kinase activity in human breast tumors with acquired tamoxifen resistance.

M. Dowsett, C. Benz, G. Scott, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Dynamic stabilization of nuclear receptor ligand binding domains by hormone or corepressor binding.

D. Moore, P. Kushner, P. Pissios, 2000, Molecular cell.

Analysis of the structural core of the human estrogen receptor ligand binding domain by selective proteolysis/mass spectrometric analysis.

J. Katzenellenbogen, K. Carlson, G. Greene, 1995, Biochemistry.